Reposted by Gabriele CorsoTom Westgarth @tomwestgarth.bsky.social · 09/01/2026Extremely exciting day for open science. Another reason to be bullish on UK AI. Boltz, a startup that emerged out of MIT to be at the frontier of small molecule and protein design, has moved to London. I hear cases like this from a few founders, often a mix of fundamentals (talent)+personal. 091
Reposted by Gabriele CorsoChaitanya K. Joshi @chaitjo.bsky.social · 08/01/2026New blog 💙: I reflect on why I worked on what I worked on... I think a PhD is a very special time. You get to challenge yourself, push your boundaries, and grow. My thoughts go against the current AI/academia narrative online, so I hope you find it interesting. chaitjo.substack.com/p/phd-thesis...chaitjo.substack.comA Cambridge PhD thesis in three research questionsGeometric Deep Learning for Molecular Modelling and Design: A personal scientific journey 1112
Gabriele Corso @gcorso.bsky.social · 08/01/2026Big news from Boltz today: we’re launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below! 2243
Reposted by Gabriele CorsoChaitanya K. Joshi @chaitjo.bsky.social · 03/12/2025Introducing gRNAde: our own little "AlphaGo Moment" for RNA design! 🧬🚀 📝: tinyurl.com/gRNAde-paper Unlike proteins, RNA design has long relied on "wisdom of the crowd" (human experts) or the slow crawl of directed evolution — gRNAde changes that! 🧵👇 2296
Reposted by Gabriele CorsoMIT Jameel Clinic @mitjameelclinic.bsky.social · 30/10/2025Join us today at MIT from 5pm-6pm for a seminar for BoltzGen, which is free and open to the public! Looking forward to seeing you all later today! 🤩 If you plan to attend, don't forget to RSVP so we can plan accordingly: luma.com/7474iho2 #AISky #AcademicSky 051
Reposted by Gabriele CorsoTim O'Donnell @timodonnell.bsky.social · 27/10/2025One cool thing about BoltzGen is the flexibility of the conditioning information you can provide (e.g. "constrain the structure of these residues and also these but let their relative placement vary"). I'm really curious to see what the community does with it! github.com/HannesStark/...github.comGitHub - HannesStark/boltzgenContribute to HannesStark/boltzgen development by creating an account on GitHub. 151
Reposted by Gabriele CorsoAnton Bushuiev @anton-bushuiev.bsky.social · 27/10/2025Very happy @roman-bushuiev.bsky.social and I joined the amazing team led by @hannes-stark.bsky.social to work on BoltzGen, a generative model for binder design based on Boltz-2. Excited what it will enable! 0134
Reposted by Gabriele CorsoAndrew Savinov @biosavinov.bsky.social · 27/10/2025Thrilled to contribute to this exciting work on protein binder design together w/ @hannes-stark.bsky.social , Felix Faltings, Regina Barzilay, Tommi Jaakkola, and co. We applied BoltzGen to design novel antimicrobial peptides targeting DNA gyrase based on inhibitory protein fragments. (1/n) 153
Reposted by Gabriele CorsoAlbert Vilella, PhD. @albertvilella.bsky.social · 27/10/2025BoltzGen now published and available as MIT licensed software 0102
Reposted by Gabriele CorsoBrian Naughton @btnaughton.bsky.social · 27/10/2025I’ve been testing BoltzGen a bit recently and while I haven’t done any experimental testing yet, the quality of the software is very clear. It installs, runs, logs everything, has tons of options. Very excited to test out the designs irl! 162
Reposted by Gabriele CorsoHannes Stark @hannes-stark.bsky.social · 26/10/2025Excited to release BoltzGen which brings SOTA folding performance to binder design! The best part of this project is collaborating with a broad network of leading wetlabs that test BoltzGen at an unprecedented scale, showing success on many novel targets and pushing the model to its limits! 310341
Gabriele Corso @gcorso.bsky.social · 17/09/2025Pretty surreal when out of the blue you see your model up on an ad on highway billboards and airport screens 🤯 (pictures from San Diego Airport and a highway in SF) 1180
Gabriele Corso @gcorso.bsky.social · 09/09/2025Boltz v2.2.1 out. A few improvements including support for .pdb templates, better treatment of stereochemistry in guidance potentials, and improved documentation. As always a great thank you to all those in the community who contributed via PR, raising issues or directly reporting issues to us. 1277
Gabriele Corso @gcorso.bsky.social · 09/09/2025Sitting at the #AITHYRA symposium hearing about incredible new high-throughput datasets 🤯! If you have developed new data that you think could improve Boltz, e.g. protein small-molecule affinity, protein protein affinity, binding site (eg via proteomics), let's work together! 🤗 040
Reposted by Gabriele CorsoChimeraX @chimerax.ucsf.edu · 20/08/2025Here's how to predict binding of tens or hundreds of small molecules to protein assemblies using Boltz 2 in ChimeraX. Accuracy depends on how similar the ligands and binding pockets are to existing experimental structures. www.rbvi.ucsf.edu/chimerax/dat... 0279
Reposted by Gabriele CorsoVojtech Spiwok @spiwokv.bsky.social · 21/08/2025On #Boltz and #drugdesign by @gcorso.bsky.social #PragueBioML @elixircz.bsky.social 031
Reposted by Gabriele CorsoMartin Steinegger 🇺🇦 @martinsteinegger.bsky.social · 15/08/2025If you use Boltz1/2, BioEmu, Chai1, or other MSA-dependent models, you’re likely using our ColabFold server. Please be considerate! Avoid large submissions across many IPs instead generate the MSA locally. Our server is an old-timer from 2014 and can’t handle that load. 36210
Reposted by Gabriele CorsoChimeraX @chimerax.ucsf.edu · 24/07/2025ChimeraX daily builds can predict binding affinity of small molecules using Boltz 2 on your Mac, Windows or Linux computer. www.rbvi.ucsf.edu/chimerax/dat... 18718
Reposted by Gabriele CorsoAlexander Ille @alexander-ille.bsky.social · 04/07/2025Excited to share our work on modeling the human protein interactome in 3D. This currently includes 1,394 interaction structures predicted with Boltz-2. Grateful for the open-access resources making this possible! Preprint: doi.org/10.1101/2025... 0154
Reposted by Gabriele CorsoAlexis Verger 🧬🧫🧪 @alexis-verger.cpesr.fr · 19/06/2025Boltz-2 : Towards accurate and efficient binding affinity prediction by @gcorso.bsky.social Saro Passaro and Jeremy Wohlwend youtu.be/iHDauMATkr0?...youtu.beBoltz-2: Towards Accurate and Efficient Binding Affinity PredictionYouTube video by Valence Labs 062
Gabriele Corso @gcorso.bsky.social · 17/06/2025Nice interview of Phil Sharp on the controversial birth of biotech and recombinant DNA with some great analogies to the current discourse on AI and gene editing! - YouTube www.youtube.com/watch?v=LLij... - Spotify spotifycreators-web.app.link/e/NNmzqnTjgUb - Apple podcasts.apple.com/us/podcast/h...youtube.comThe Nobel that Sparked Biotech - Prof Phil SharpYouTube video by Health Horizons 060
Gabriele Corso @gcorso.bsky.social · 14/06/2025Thank you everyone for attending the Boltz-2 Boston, San Francisco and Paris events this week! Given the success of the in-person seminars and the many requests, we are organizing a virtual seminar on Tuesday at 12pm ET / 6pm CET! Sign up here: lu.ma/4bpuwbsr 2161
Reposted by Gabriele CorsoScience X / Phys.org @sciencex.bsky.social · 10/06/2025A new AI model jointly predicts protein structure and binding affinity, enabling rapid, accurate screening of small molecules and accelerating early-stage drug discovery. Boltz-2 is now open source.phys.orgProtein-binding affinity model expands role of AI in drug discoveryUnderstanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease mechanisms and developing life-saving drugs. 022
Reposted by Gabriele CorsoRecursion @recursionpharma.bsky.social · 13/06/2025Open science, activated. Since the release of Boltz-2 last Friday – the new open-source protein structure and protein binding affinity model from MIT & Recursion – we’ve been introducing the model to the broader community and the reception has been terrific. 🧵 132
Reposted by Gabriele CorsoRecursion @recursionpharma.bsky.social · 13/06/2025On June 18 at the Molecular Machine Learning Conference (MoML) at MILA, Gabriele Corso, one of the lead researchers behind Boltz-2, will present more on this latest breakthrough in AI drug discovery alongside researchers from Valence. 👉 Learn more: portal.ml4dd.com #MOML2025portal.ml4dd.comHome | MoML 2025 021
Reposted by Gabriele CorsoKyle Tretina @allthingsapx.bsky.social · 13/06/2025Boltz-2 just dropped: open-source AI that predicts both protein complex folds ✚ binding affinities in one shot 🚀 This is a win for protein AI, but let's not forget MSAs, the bioinformatics backbone many structure models lean on. 172
Reposted by Gabriele CorsoOpen Free Energy @openfree.energy · 13/06/2025It's exciting to see our software used as a benchmark for cutting-edge AI methods! 061
Reposted by Gabriele CorsoC&EN (Chemical & Engineering News) @cenmag.bsky.social · 10/06/2025A team led by Regina Barzilay, a computer science professor at MIT, has launched Boltz-2, an algorithm that unites protein folding and prediction of small-molecule binding affinity in one package. cen.acs.org/pharmaceutic... #chemsky 🧪cen.acs.orgMIT and Recursion partner for AI drug discovery toolFreely available Boltz-2 algorithm can predict small-molecule binding affinities 1155
Reposted by Gabriele CorsoMIT Jameel Clinic @mitjameelclinic.bsky.social · 10/06/2025What a turnout! 🤯 Thank you to the 400+ attendees who came to listen to the first-ever Boltz-2 presentation in-person and for asking great questions! We look forward to seeing how Boltz-2 will empower future research in biomolecular structure prediction! 🧬🔥 #AIsky 142
Reposted by Gabriele CorsoThe Mark Foundation for Cancer Research @themarkfdn.bsky.social · 09/06/2025Boltz-2 is here—and it’s poised to transform preclinical drug development. We were lucky to get a preview from Regina Barzilay at our 2025 Scientific Symposium, and we’re proud to support her work on the @cancergrand.bsky.social Matchmakers team. www.cancergrandchallenges.org/news/boltz-2...cancergrandchallenges.orgBoltz-2: democratising the future of drug designOpen source structure prediction with binding affinity 031
Reposted by Gabriele CorsoMIT Jameel Clinic @mitjameelclinic.bsky.social · 09/06/2025'93 Nobel Prize laureate and Jameel Clinic Advisory Board Chair Phil Sharp breaks down why Boltz-2 is so groundbreaking. Join @gcorso.bsky.social + @jeremywohlwend.bsky.social today @ 4pm in Stata Center for their talk on Boltz-2! 🗓️RSVP: jclinic.mit.edu/events/unvei... 🎬: youtu.be/YDrFggLBEQw?...youtu.be'93 Nobel Laureate Phillip Sharp on significance of Boltz-2 and affinity bindingYouTube video by MIT Jameel Clinic - AI & Health 131
Reposted by Gabriele CorsoJan Gebauer @gebauer.bsky.social · 09/06/2025This sounds really interesting! Eager to test it with some structures we have lying around. 👍 021
Gabriele Corso @gcorso.bsky.social · 10/06/2025Wow that was fast!! Looking forward to seeing this! @nboyd.bsky.social 061
Reposted by Gabriele CorsoAlexander Ille @alexander-ille.bsky.social · 08/06/2025Truly remarkable work. Looking forward to using it! 031
Reposted by Gabriele CorsoDiego del Alamo @delalamo.xyz · 07/06/2025Lots of work seems to have gone into the Boltz-2 data curation process to learn binding affinities 2262
Reposted by Gabriele CorsoRecursion @recursionpharma.bsky.social · 06/06/2025More on Boltz-2, the new open source AI model from MIT & Recursion capable of predicting protein binding affinity w/ unprecedented speed, scale & accuracy -- the 1st model to combine structure & binding affinity prediction, approaching FEP accuracy w/ 1000X the speed. www.youtube.com/watch?v=gRtr...youtube.comNew Open Source Model from MIT & Recursion Solves Major Hurdle in AI Drug DiscoveryYouTube video by Recursion 0165
Reposted by Gabriele CorsoLee Zamparo @lzamparo.bsky.social · 06/06/2025A Boltz-specifiic slack: boltz.bio/join-slackboltz.bioJoin boltz-community on SlackSlack is a new way to communicate with your team. It’s faster, better organized, and more secure than email. 011
Reposted by Gabriele CorsoBen Fry @benf549.bsky.social · 07/06/2025Trying out the Boltz-2 affinity prediction on the Exatecan binders we generated with LASErMPNN and NISE. Affinity prediction still clearly has room to improve, but the model seems to be able to identify the highest affinity mutant in this small dataset. Thanks to @gcorso.bsky.social and team! 1/2 171
Gabriele Corso @gcorso.bsky.social · 06/06/2025Thank you everyone for the feedback on Boltz-2 and especially to those who have already helped us fix some elements of the repo! To keep the discussion going, please join our Slack community channel boltz-community.slack.com/join/shared_... and the events in Boston, SF, Paris and Montreal! 👇 170
Reposted by Gabriele CorsoMIT Jameel Clinic @mitjameelclinic.bsky.social · 06/06/2025Delighted to announce the release of Boltz-2, which demonstrates unprecedented accuracy in predicting structure and binding affinity! Congrats to Sara Passaro, @gcorso.bsky.social + @jeremywohlwend.bsky.social on this stunning achievement! 📄Paper: bit.ly/boltz2-pdf 💻Code: github.com/jwohlwend/bo... 1146
Reposted by Gabriele CorsoMIT Jameel Clinic @mitjameelclinic.bsky.social · 06/06/2025Join @gcorso.bsky.social and @jeremywohlwend.bsky.social on Monday, June 9 @ 4pm in the Stata Center for their presentation on the future of biomolecular modeling! 🗓️RSVP: jclinic.mit.edu/events/unvei...jclinic.mit.eduUnveiling Boltz-2 – MIT Jameel Clinic 021
Reposted by Gabriele CorsoKarel "CaCO3" Berka @krapnik.bsky.social · 06/06/2025Binding affinities with #Alphafoldology using Boltz-2 ligands and ensembles included 071
Reposted by Gabriele CorsoFay Lin @faylinphd.bsky.social · 06/06/2025Boltz-2 now predicts molecular binding affinity at newfound speed and accuracy - and it's open source! The permissive MIT license allows commercial drug developers to apply proprietary data and offers an advance over the structure prediction capabilities of AlphaFold 3. tinyurl.com/37c96c6ygenengnews.comBoltz-2 Released to Democratize AI Molecular Modeling for Drug DiscoveryThe MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery. 1184
Reposted by Gabriele CorsoFay Lin @faylinphd.bsky.social · 06/06/2025In collaboration with @recursionpharma.bsky.social, the work was led by Gabriele Corso @gcorso.bsky.social, Saro Passaro, and Jeremy Wohlwend from the lab of Regina Barzilay at @mit.edu! 011
Reposted by Gabriele CorsoRebecca Eccles @rebeccaeccles.bsky.social · 06/06/2025Move over AlphaFold3. Boltz-2 has arrived, bringing affinity prediction for protein-small molecule interactions! Can’t wait to see what this group does next. Congrats to all @gcorso.bsky.social Was a pleasure writing this: www.cancergrandchallenges.org/news/boltz-2...cancergrandchallenges.orgBoltz-2: democratising the future of drug designOpen source structure prediction with binding affinity 1378
Reposted by Gabriele Corsoda spreadsheet lover @chemotaxis.bsky.social · 06/06/2025biologists are actually doing incredible things with AI 062